Identification of cancer stem cell markers in human malignant mesothelioma cells
- Division of Clinical Immunology, Institute of Medical Science, University of Tokyo, Tokyo (Japan)
- Departments of Medical Oncology, Yamaguchi-Ube Medical Center, Yamaguchi (Japan)
- Department of Respiratory Medicine, Okayama Rosai Hospital, Okayama (Japan)
- Department of Pathology, Keio University School of Medicine, Tokyo (Japan)
- Drug Development Program, Nevada Cancer Institute, Las Vegas, NV (United States)
Research highlights: {yields} We performed serial transplantation of surgical samples and established new cell lines of malignant mesothelioma. {yields} SP cell and expressions of CD9/CD24/CD26 were often observed in mesothelioma cell lines. {yields} SP and CD24{sup +} cells proliferated by asymmetric cell division-like manner. CD9{sup +} and CD24{sup +} cells have higher potential to generate spheroid colony. {yields} The marker-positive cells have clear tendency to generate larger tumors in mice. -- Abstract: Malignant mesothelioma (MM) is an aggressive and therapy-resistant neoplasm arising from the pleural mesothelial cells and usually associated with long-term asbestos exposure. Recent studies suggest that tumors contain cancer stem cells (CSCs) and their stem cell characteristics are thought to confer therapy-resistance. However, whether MM cell has any stem cell characteristics is not known. To understand the molecular basis of MM, we first performed serial transplantation of surgical samples into NOD/SCID mice and established new cell lines. Next, we performed marker analysis of the MM cell lines and found that many of them contain SP cells and expressed several putative CSC markers such as CD9, CD24, and CD26. Interestingly, expression of CD26 closely correlated with that of CD24 in some cases. Sorting and culture assay revealed that SP and CD24{sup +} cells proliferated by asymmetric cell division-like manner. In addition, CD9{sup +} and CD24{sup +} cells have higher potential to generate spheroid colony than negative cells in the stem cell medium. Moreover, these marker-positive cells have clear tendency to generate larger tumors in mouse transplantation assay. Taken together, our data suggest that SP, CD9, CD24, and CD26 are CSC markers of MM and could be used as novel therapeutic targets.
- OSTI ID:
- 22204759
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 404, Issue 2; Other Information: Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia
Amplification of tumor inducing putative cancer stem cells (CSCs) by vitamin A/retinol from mammary tumors